EGFR Level Predicts Survival Benefit of Cetuximab in NSCLC

Friday, November 4, 2011 (Last Updated: 11/07/2011)

HR

Specialties Hematology & Oncology
Pharmacy
Pulmonology
Family Practice
Internal Medicine
Nursing
Pathology

Copyright © 2011 HealthDay. All rights reserved.

Blogs

Cancer Rehabilitation for Head & Neck Cancers [Webinar]
by OncoLink Editorial Team
January 15, 2015

In Celebration of Eric Ott
by Bob Riter
August 17, 2015